SCHEMBL670604

SCHEMBL670604

COC(=O)c1[c]cccc1C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
TSHR P16473 2/20 0.50
ALDH1A1 P00352 3/20 0.48
HSD17B10 Q99714 3/20 0.48
CFTR P13569 1/20 0.48
KDM4E B2RXH2 3/20 0.47
POLB P06746 2/20 0.47
ATM Q13315 1/20 0.47
KMT2A Q03164 2/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA5A P35218 1/20 0.43
CA9 Q16790 1/20 0.43
MAPT P10636 1/20 0.43
ALOX15 P16050 1/20 0.43
SLC6A3 Q01959 4/20 0.42
MYC P01106 1/20 0.42
SLC6A4 P31645 2/20 0.41
GLA P06280 1/20 0.41
APOBEC3A P31941 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11284039 0.87 TSHR (0.56) LMNATSHRALDH1A1HSD17B10KDM4E
SCHEMBL8728062 0.84 SLC6A3 (0.50) LMNATSHRALDH1A1HSD17B10CFTR
SCHEMBL1967335 0.81 TSHR (0.41) LMNATSHRALDH1A1HSD17B10CFTR
SCHEMBL1098615 0.81 TSHR (0.50) LMNATSHRALDH1A1HSD17B10CFTR
SCHEMBL7406380 0.81 LMNA (0.55) LMNATSHRALDH1A1HSD17B10CFTR
SCHEMBL7471896 0.81 CA1 (0.53) LMNATSHRALDH1A1HSD17B10CFTR
SCHEMBL1967336 0.79 SLC6A3 (0.51) LMNATSHRALDH1A1HSD17B10CFTR
SCHEMBL6790765 0.79 ALDH1A1 (0.52) LMNATSHRALDH1A1HSD17B10CFTR
SCHEMBL7006875 0.79 ALDH1A1 (0.56) LMNATSHRALDH1A1HSD17B10CFTR
SCHEMBL5106840 0.79 LMNA (0.48) LMNATSHRALDH1A1HSD17B10CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2606054-A1 FUNCTIONALIZED POLYHEDRAL OCTAVINYLSILSESQUIOXANES Adam Mickiewicz University (PL) 2013-06-26 EP claimed
WO-2012023867-A1 FUNCTIONALIZED POLYHEDRAL OCTAVINYLSILSESQUIOXANES ADAM MICKIEWICZ UNIVERSITY (PL) 2012-02-23 WO claimed
WO-2008073067-A1 NOVEL SPIRO-QUINUCLIDINYL DERIVATIVES FOR THE TREATMENT OF THE CENTRAL NERVOUS SYSTEM DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 2008-06-19 WO claimed
US-4457866-A MEDICAL DIAGNOSIS BEHRINGWERKE AKTIENGESELLSCHAFT (DE) 1984-07-03 US claimed
EP-0025190-B1 CHROMOGENIC COMPOUNDS AND THEIR USE AS ENZYMATIC SUBSTRATES BEHRINGWERKE Aktiengesellschaft (DE) 1984-06-13 EP claimed
US-4042577-A POLYESTERS, POLYAMIDES, CELLULOSE ACETATES SANDOZ LTD. (CH) 1977-08-16 US claimed
US-3930869-A MEROCYANINE DYES CONTAINING 5,6-BENZOQUINOLINE AND RHODANINE MOIETIES MITSUBISHI PAPER MILLS, LTD. (JA) 1976-01-06 US claimed
WO-2021049298-A1 COMPOSITION, PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING DEVICE パナソニックIPマネジメント株式会社 2021-03-18 WO disclosed
EP-2239057-B1 Asymmetric catalyst and process for preparing optically active alcohols using the same KANTO KAGAKU (JP) 2015-06-03 EP disclosed
US-8232420-B2 Asymmetric catalyst and process for preparing optically active alcohols using the same KANTO KAGAKU KABUSHIKI KAISHA (JP) 2012-07-31 US disclosed
US-8211984-B2 Ring-opening metathesis polymer, hydrogenated product thereof, method for preparing the same, and use thereof MITSUI CHEMICALS, INC. (JP) 2012-07-03 US disclosed
US-20100261924-A1 ASYMMETRIC CATALYST AND PROCESS FOR PREPARING OPTICALLY ACTIVE ALCOHOLS USING THE SAME KANTO KAGAKU KABUSHIKI KAISHA (JP) 2010-10-14 US disclosed
EP-2239057-A1 Asymmetric catalyst and process for preparing optically active alcohols using the same Kanto Kagaku Kabushiki Kaisha (JP) 2010-10-13 EP disclosed
WO-1994019335-A1 THIAZOLE OR IMIDAZOLE DERIVATIVES AS MAILLARD REACTION INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-09-01 WO disclosed
US-4918046-A DISULFONATES AND COLORLESS OR LIGHT-COLORED COLORING MATERIAL; DISCOLORATION INHIBITION ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1990-04-17 US disclosed
US-4457866-A MEDICAL DIAGNOSIS BEHRINGWERKE AKTIENGESELLSCHAFT (DE) 1984-07-03 US disclosed
US-4392999-A COLORFAST BROWN, RED AND ORANGE CIBA-GEIGY CORPORATION (US) 1983-07-12 US disclosed
US-4313874-A DYEING POLYESTERS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1982-02-02 US disclosed
US-4229344-A Monazo pigments containing hydroxynaphthoylaminobenzimidazalone radical CIBA-GEIGY CORPORATION (US) 1980-10-21 US disclosed
US-4202814-A AZO DYES GIVING FAST RED COLOR CIBA-GEIGY CORPORATION (US) 1980-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261924-A1 ASYMMETRIC CATALYST AND PROCESS FOR PREPARING OPTICALLY ACTIVE ALCOHOLS USING THE SAME ADH1A, ADH1C, ADH5 LMNA 2545/4885TSHR 238/4885ALDH1A1 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.